NO812075L - Farmasoeytisk preparat, samt fremgangsmaate til fremstilling derav. - Google Patents
Farmasoeytisk preparat, samt fremgangsmaate til fremstilling derav.Info
- Publication number
- NO812075L NO812075L NO812075A NO812075A NO812075L NO 812075 L NO812075 L NO 812075L NO 812075 A NO812075 A NO 812075A NO 812075 A NO812075 A NO 812075A NO 812075 L NO812075 L NO 812075L
- Authority
- NO
- Norway
- Prior art keywords
- steroid
- phase
- oil
- propylene glycol
- solution
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title claims description 4
- 238000000034 method Methods 0.000 title claims 5
- 150000003431 steroids Chemical class 0.000 claims description 35
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 33
- 239000000839 emulsion Substances 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000003246 corticosteroid Substances 0.000 claims description 12
- 239000003995 emulsifying agent Substances 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 11
- 239000006071 cream Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 6
- 230000000699 topical effect Effects 0.000 claims description 6
- 206010040880 Skin irritation Diseases 0.000 claims description 4
- 230000036556 skin irritation Effects 0.000 claims description 4
- 231100000475 skin irritation Toxicity 0.000 claims description 4
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 claims description 3
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 3
- 229960004436 budesonide Drugs 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 150000002191 fatty alcohols Chemical class 0.000 claims description 2
- -1 methylenedioxypregna-1,4-diene-11,21-diol-3,20-dione Chemical compound 0.000 claims description 2
- 239000012047 saturated solution Substances 0.000 claims description 2
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003921 oil Substances 0.000 description 26
- 235000019198 oils Nutrition 0.000 description 26
- 238000004090 dissolution Methods 0.000 description 10
- 239000004264 Petrolatum Substances 0.000 description 6
- 235000019271 petrolatum Nutrition 0.000 description 6
- 229940066842 petrolatum Drugs 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 4
- 229960001334 corticosteroids Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- SNHRLVCMMWUAJD-SUYDQAKGSA-N betamethasone valerate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O SNHRLVCMMWUAJD-SUYDQAKGSA-N 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical class CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229960001067 hydrocortisone acetate Drugs 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012875 nonionic emulsifier Substances 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000010913 used oil Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/066—Multiple emulsions, e.g. water-in-oil-in-water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8004580A SE8004580L (sv) | 1980-06-19 | 1980-06-19 | Farmaceutisk beredning |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO812075L true NO812075L (no) | 1981-12-21 |
Family
ID=20341257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO812075A NO812075L (no) | 1980-06-19 | 1981-06-18 | Farmasoeytisk preparat, samt fremgangsmaate til fremstilling derav. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4363806A (fr) |
| EP (1) | EP0042827A3 (fr) |
| JP (1) | JPS5731700A (fr) |
| DD (1) | DD159736A5 (fr) |
| DK (1) | DK262681A (fr) |
| ES (1) | ES503132A0 (fr) |
| FI (1) | FI811745L (fr) |
| GR (1) | GR74568B (fr) |
| NO (1) | NO812075L (fr) |
| PT (1) | PT73215B (fr) |
| SE (1) | SE8004580L (fr) |
| ZA (1) | ZA813465B (fr) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ200918A (en) * | 1981-07-02 | 1985-07-31 | Gist Brocades Nv | Stable fatty oil-in-water emulsion cream for topical application |
| DE3225849A1 (de) * | 1982-07-07 | 1984-01-19 | Schering Ag | Kortikoidhaltige zubereitung zur topischen applikation |
| DE3225848A1 (de) * | 1982-07-07 | 1984-01-19 | Schering AG, 1000 Berlin und 4709 Bergkamen | Kortikoidhaltige zubereitung zur topischen applikation |
| LU84514A1 (fr) * | 1982-12-09 | 1984-10-22 | Oreal | Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone |
| JP2655190B2 (ja) * | 1989-06-21 | 1997-09-17 | エスエス製薬 株式会社 | コルチコステロイド含有軟膏剤 |
| US6469015B1 (en) | 1990-01-26 | 2002-10-22 | Novartis International Pharmaceutical Ltd | Pharmaceutical formulation |
| FR2679788B1 (fr) * | 1991-08-02 | 1994-03-18 | Thorel Jean Noel | Structures d'emulsions polyphasiques autostabilisees. |
| DE4311445C1 (de) * | 1993-04-07 | 1994-10-06 | Henkel Kgaa | Multiple W/O/W-Emulsionen, Verfahren zu deren Herstellung und ihre Verwendung |
| FR2721212B1 (fr) * | 1994-06-17 | 1996-09-13 | Pf Medicament | Composition et procédé d'obtention d'une émulsion de désonide. |
| US5589177A (en) * | 1994-12-06 | 1996-12-31 | Helene Curtis, Inc. | Rinse-off water-in-oil-in-water compositions |
| ES2118033B1 (es) * | 1996-02-16 | 1999-07-01 | Bial Ind Farmaceutica S A | Formulacion farmaceutica antiinflamatoria. |
| US5853740A (en) * | 1996-08-07 | 1998-12-29 | Abbott Laboratories | Delivery system for pharmaceutical agents encapsulated with oils |
| GB9823036D0 (en) | 1998-10-22 | 1998-12-16 | Glaxo Group Ltd | Fluticasone lotion having improved vasoconstrictor activity |
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| AU2003279493B2 (en) | 2002-10-25 | 2009-08-20 | Foamix Pharmaceuticals Ltd. | Cosmetic and pharmaceutical foam |
| US20080031907A1 (en) * | 2002-10-25 | 2008-02-07 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| DE602004016958D1 (de) * | 2003-02-05 | 2008-11-20 | Galderma Res & Dev | Umkehremulsion mit mindestens einem gegenüber wasser empfindlichen wirkstoff und ihre anwendungen in kosmetik und dermatologie |
| FR2850575B1 (fr) * | 2003-02-05 | 2007-04-13 | Galderma Res & Dev | Composition de type emulsion inverse contenant au moins un actif sensible a la presence d'eau, et ses utilisations en dermatologie |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| WO2009069006A2 (fr) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Peroxyde de benzoyle contenant de la mousse |
| WO2009072007A2 (fr) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Porteurs, formulations, procédés pour formuler des agents actifs instables pour application externe et utilisations associées |
| US20120087872A1 (en) | 2009-04-28 | 2012-04-12 | Foamix Ltd. | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof |
| CA2769625C (fr) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Compositions hydro-alcooliques moussantes non tensioactives, mousses legeres, et leurs utilisations |
| WO2011013008A2 (fr) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Compositions hydro-alcooliques moussantes à base d'agents non tensioactifs non polymères, mousses légères, et leurs utilisations |
| UA108360C2 (uk) * | 2009-10-01 | 2015-04-27 | Тверда фармацевтична композиція кортикостероїду, що розпадається у ротовій порожнині | |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| CN102686205A (zh) | 2009-10-02 | 2012-09-19 | 弗艾米克斯有限公司 | 局部四环素组合物 |
| WO2015034678A2 (fr) | 2013-09-06 | 2015-03-12 | Aptalis Pharmatech, Inc. | Corticostéroïde contenant des compositions de comprimés se désintégrant par voie orale pour œsophagite à éonisophiles |
| TWI728172B (zh) | 2016-08-18 | 2021-05-21 | 美商愛戴爾製藥股份有限公司 | 治療嗜伊紅性食道炎之方法 |
| MX2017011630A (es) | 2016-09-08 | 2018-09-25 | Foamix Pharmaceuticals Ltd | Composiciones y metodos para tratar rosacea y acne. |
| DK3638251T3 (da) * | 2017-06-12 | 2024-05-13 | Lakewood Amedex Inc | Bisphosphocin gel formuleringer og brug deraf |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1080994A (en) * | 1963-10-25 | 1967-08-31 | Nat Res Dev | Injectable emulsions containing antigens |
| US3395028A (en) * | 1966-09-12 | 1968-07-30 | Drackett Co | Wax composition and method for making the same |
| DE1792410B2 (de) * | 1967-09-01 | 1980-03-13 | Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm | Arzneimittelzubereitung zur intravenösen Injektion |
| US3996359A (en) * | 1972-05-19 | 1976-12-07 | Ab Bofors | Novel stereoisomeric component A of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steroid 21-acylates, compositions thereof, and method of treating therewith |
| SE378109B (fr) * | 1972-05-19 | 1975-08-18 | Bofors Ab | |
| US3992534A (en) * | 1972-05-19 | 1976-11-16 | Ab Bofors | Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods |
| US3892857A (en) * | 1972-11-24 | 1975-07-01 | Squibb & Sons Inc | Steroid formulation |
| GB1478009A (en) * | 1973-04-02 | 1977-06-29 | Glaxo Lab Ltd | Pharmaceutical compositions |
| DE2514873C2 (de) * | 1975-04-05 | 1983-12-29 | Merck Patent Gmbh, 6100 Darmstadt | Salbengrundlage |
| GB1541463A (en) * | 1975-10-11 | 1979-02-28 | Lion Dentifrice Co Ltd | Process for prparing a multiple emulsion having a dispersing form of water-phase/oil-phase/water-phase |
| US4048310A (en) * | 1976-02-24 | 1977-09-13 | E. R. Squibb & Sons, Inc. | Topical steroid formulation in form of lotion or cream |
| DE2714065A1 (de) * | 1977-03-30 | 1978-10-12 | Boehringer Mannheim Gmbh | Instillationszubereitung |
| US4284630A (en) * | 1978-03-22 | 1981-08-18 | Yu Ruey J | Stabilized water-in-oil emulsions |
| US4198403A (en) * | 1978-04-05 | 1980-04-15 | Syntex (U.S.A.) Inc. | 17 Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes |
| JPS5612307A (en) * | 1979-07-09 | 1981-02-06 | Lion Corp | External preparation |
-
1980
- 1980-06-19 SE SE8004580A patent/SE8004580L/xx not_active Application Discontinuation
-
1981
- 1981-05-22 ZA ZA00813465A patent/ZA813465B/xx unknown
- 1981-06-04 FI FI811745A patent/FI811745L/fi not_active Application Discontinuation
- 1981-06-10 EP EP81850105A patent/EP0042827A3/fr not_active Withdrawn
- 1981-06-12 US US06/272,881 patent/US4363806A/en not_active Expired - Fee Related
- 1981-06-16 DK DK262681A patent/DK262681A/da not_active Application Discontinuation
- 1981-06-17 ES ES503132A patent/ES503132A0/es active Granted
- 1981-06-17 PT PT73215A patent/PT73215B/pt unknown
- 1981-06-17 DD DD81230895A patent/DD159736A5/de unknown
- 1981-06-18 NO NO812075A patent/NO812075L/no unknown
- 1981-06-18 GR GR65272A patent/GR74568B/el unknown
- 1981-06-19 JP JP9409781A patent/JPS5731700A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK262681A (da) | 1981-12-20 |
| ZA813465B (en) | 1982-06-30 |
| SE8004580L (sv) | 1981-12-20 |
| ES8203605A1 (es) | 1982-04-16 |
| PT73215A (en) | 1981-07-01 |
| EP0042827A3 (fr) | 1983-02-16 |
| DD159736A5 (de) | 1983-04-06 |
| ES503132A0 (es) | 1982-04-16 |
| EP0042827A2 (fr) | 1981-12-30 |
| JPS5731700A (en) | 1982-02-20 |
| US4363806A (en) | 1982-12-14 |
| FI811745L (fi) | 1981-12-20 |
| GR74568B (fr) | 1984-06-29 |
| PT73215B (en) | 1982-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO812075L (no) | Farmasoeytisk preparat, samt fremgangsmaate til fremstilling derav. | |
| US4818521A (en) | Emulsion cosmetic stably containing vitamin C | |
| US5422361A (en) | Stable cream and lotion bases for lipophilic drug compositions | |
| US4794106A (en) | Cream | |
| US5612327A (en) | 1α,24-(OH)2 -cholecalciferol emulsion composition and method for treating psoriasis | |
| JPS63150221A (ja) | 結晶性薬物含有乳化組成物 | |
| CA1085725A (fr) | Steroide pour applications locales | |
| AU6569398A (en) | Emulsifier composition for skin care formulations | |
| NO832243L (no) | Salvegrunnlag for topisk paafoering. | |
| JP4511639B2 (ja) | ビタミンｄ３誘導体を含有するクリーム剤 | |
| EP0146065B1 (fr) | Crème de bêtaméthazone dipropionate | |
| WO1981002673A1 (fr) | Composition pour la peau et les ongles contenant un complexe de phosphate-trialcanolamine | |
| TW202034892A (zh) | 包含奈米脂質體之油水型化妝品組成物 | |
| CA2251702C (fr) | Composition biologiquement active | |
| FI79941B (fi) | Blandningar foer lokal anvaendning pao huden. | |
| US4279901A (en) | Topical ointment | |
| CN101332183A (zh) | 含有甾类化合物的o/w型乳化制剂 | |
| JPH0149128B2 (fr) | ||
| JPH0261442B2 (fr) | ||
| JPS62215528A (ja) | 経皮投与製剤 | |
| Arvouet-Grand et al. | Formulation of Propolis Extract Emulsions. II. O/W Creams Formulated with Self-Emulsifying Bases | |
| CA2156396A1 (fr) | Preparation dermatologique stable contenant de l'acide mycophenolique | |
| JPH1112173A (ja) | 水分散系外用剤 | |
| JPS6226210A (ja) | 外用剤 |